Literature DB >> 34548795

Genomic and Phenotypic Characteristics for Vibrio vulnificus Infections.

Jiajie Zhang1, Yicheng Huang1, Hao Xu2, Shuaibing Ying2, Hongying Pan1, Wei Yu2.   

Abstract

BACKGROUND: Vibrio vulnificus (VV) is a causative agent of foodborne diseases with high mortality. The aim of this study was to investigate the genomic and phenotypic profiles of VV.
METHODS: Six VV isolates were collected and conducted whole-genome sequencing. Biofilm formation and anti-complement killing test were performed to evaluate the pathogenicity. Subsequently, 157 publicly available genomes of VV isolates were selected to determine the evolutionary relationship.
RESULTS: The resistant genes norM and tet34 were identified in six isolates. A total of 156 virulence genes were identified. However, there is no obvious difference between strains isolated from blood and puncture fluid. The tendency of growth for six isolates decreased with the lapse of time, while the biofilm formation increased. The genes tadC and flp related to Flp pili were found in isolate 25506 and 30896, resulting in more obvious biofilm formation. In addition, the survival rate of 19656 was less than 20% due to lack of one genomic island including virulence genes (impD-H, clpV-1) relevant to type VI secretion system (T6SS). Multi-locus sequence typing (MLST) revealed 95 different STs and 19 novel STs, indicating that the tendency of 163 isolates was sporadic. Further comparative genomics analysis clearly classified 163 isolates into three distinct evolutionary lineages.
CONCLUSION: VV infections were sporadic in humans and the environment. Virulence genes impD-H and clpV-1 related to T6SS were associated with pathogenicity phenotype of VV.
© 2021 Zhang et al.

Entities:  

Keywords:  biofilm; resistance genes; type VI secretion system; virulent factors

Year:  2021        PMID: 34548795      PMCID: PMC8449862          DOI: 10.2147/IDR.S331468

Source DB:  PubMed          Journal:  Infect Drug Resist        ISSN: 1178-6973            Impact factor:   4.003


Background

Fisheries and aquaculture are becoming increasingly intensive to meet recent human consumption, resulting in proliferation of marine pathogens and food security concerns.1,2 Vibrio species, as one of the most dangerous foodborne pathogens, cause vibriosis in human around the world.3 It has been reported that vibriosis resulted in 80,000 illnesses and 100 deaths each year in the United States.4 Among Vibrio species, V. vulnificus (VV) is responsible for multiple outbreaks in fish farms and for the highest fatality rate in human.4–6 Previous study demonstrated VV could activate genes involved in colonization and resistance in the blood, correlating with global warming.7 Surveillance data from the Cholera and Other Vibrio Illness Surveillance (COVIS) system indicated an increase tendency of VV infections in recent years in the United States.4 In China, VV infections are very rare and there are no reported outbreaks in human.8 Epidemiological investigations showed an overlap in the distribution of VV among marine animals, aquariums, and human.9,10 However, the genetic factors that differentiate clinical or environmental isolates remain enigmatic. Pangenome analysis has identified VV isolates cohabitated with both commensal and bloomer ecotypes in the mucosa of eels from aquaculture farms, raising concerns about man-made environments.11 The global overview of VV epidemiology is still limited partly due to imperfect surveillance systems. Therefore, the aim of this study was to investigate the genomic and phenotypic profiles of VV isolated from our hospital and gain insights into the evolutionary differences of VV in human and non-human.

Methods

Collection of Bacterial Strains and Whole-Genome Sequencing (WGS)

Six VV isolates (5955, 19656, 25506, 30896, 32999, 41678) were collected from patients as described previously.12 Genomic DNA was extracted by FastDNA SPIN Kit for Soil (MP Biomedicals, United States) and sequenced using HiSeq 2000 (Illumina, SanDiego, CA, USA). All genomes were annotated using Prokka.13 The analysis of pathogenicity, virulence genes, resistance genes and genomic island was performed as described previously.14 The Whole Genome Shotgun BioProject for the six VV isolates has been deposited under BioProject accession No. PRJNA714541.

Growth Curve and Biofilm Formation Testing

Six isolates were inoculated into 96-well polystyrene microtiter plates containing 200 μL Mueller–Hinton broth (MHB) for 24 h, 48 h, and 72 h. After static incubation, the absorbance was tested using a plate reader at 600 nm. Then, the biofilm formation was further tested as described previously.15

Anti-Complement Killing Test

Mouse serum was obtained from Guangzhou Ruite Biotechnology (Guangzhou, China). The serum was placed in a water bath at 56°C for 30 min to inactivate complement, generating inactive serum. The overnight bacterial culture was diluted to a cell density of 2×106 CFU/mL, and normal and inactivated sera (180 μL) were separately mixed with 20 μL bacterial suspension and incubated at 37°C for 1 h. Samples were diluted 100-fold and spread onto plates. After overnight incubation, the colonies on plates were counted. The bacterial survival rate was calculated using the following formula: Bacterial survival rate = (number of colonies with normal serum/number of colonies with inactivated serum) × 100%.

Comparative Genomic Analysis

Six genomes in the present study and 157 publicly available VV genomes were selected to determine the evolutionary relationship (). Multi-locus sequence typing (MLST) analysis used an online tool (). Core genome for the genome dataset was calculated by Roary (). The resulting consensus tree was visualized and edited using the Interactive Tree of Life (iTOL).16

Results

Antibiotic Resistance Mechanism of VV

The antimicrobial susceptibility testing of six isolates was performed in a previous study.12 Except polymyxin B and gentamicin, six VV isolates were sensitive to other tested antibiotics. The resistant genes norM and tet34 were identified in all six included isolates, inducing efflux pump and tetracycline resistance, respectively.

Virulence Genes

A total of 156 virulence genes were identified, and 133 genes were found in all six isolates (). These genes are possibly associated with pathogenicity, including capsular polysaccharide, flagella, flp pili, multifunctional-auto processing repeats-in-toxin (MARTX) toxin, hemolysin, mannose-sensitive hemagglutinin, and two secretion systems (type II and VI). There is no obvious difference between strains isolated from blood and puncture fluid.

Characteristics of Pathogenicity

As shown in Figure 1A, the growth of six isolates diminished with the lapse of time. However, the tendency of biofilm formation increased with the time in all isolates, especially for isolates 25506 and 30896 (Figure 1B). The genes (tadC and flp) related to Flp pili were found only in isolates 25506 and 30896. In addition, the survival rate of 19656 was less than 20% (). Notably, except 19656, other five isolates had one genomic island including virulence genes (impD-H, clpV-1) related to type VI secretion system (T6SS) (Figure 2).
Figure 1

Growth curve and the biofilm formation of six VV isolates. (A) growth curve; (B) biofilm formation.

Figure 2

Schematic diagram of one genomic island in five VV isolates. The arrows represent the positions and direction of the elements.

Growth curve and the biofilm formation of six VV isolates. (A) growth curve; (B) biofilm formation. Schematic diagram of one genomic island in five VV isolates. The arrows represent the positions and direction of the elements.

Comparative Genomics Analysis

The data of our genome collections showed the incidence of VV infections was highest in the United States. There were 95 different STs and 19 novel STs among the 163 isolates. The most common STs were ST136 (8, 4.9%), ST112 (7, 4.3%), and ST8 (6, 3.7%). Therefore, the epidemic of VV infections had sporadic tendency. Comparative genomics analysis based on core genome clearly classified 163 isolates into three distinct evolutionary lineages with most isolates grouped into lineages III (Figure 3). Seven and fifty-six isolates detected in this study were grouped into lineages I and II, respectively. Isolates in lineages I were only collected from environment and clinic. The proportion of strains isolated from human in lineages II (16, 28.6%) was higher than that in lineages III (20, 20%).
Figure 3

Core-genome-based phylogenetic tree of 163 VV isolates, including 6 isolates from this study and 157 strains downloaded from NCBI genome database. STs of the isolates is labelled in the outer ring. The source of all isolates is presented in the middle ring. The location of the isolates is colored in the inner ring. The number of isolates in the present study was colored in red.

Core-genome-based phylogenetic tree of 163 VV isolates, including 6 isolates from this study and 157 strains downloaded from NCBI genome database. STs of the isolates is labelled in the outer ring. The source of all isolates is presented in the middle ring. The location of the isolates is colored in the inner ring. The number of isolates in the present study was colored in red.

Discussion

VV is a zoonotic pathogen, posing a threat to marine animals, aquariums and humans.1,3–5 Here, a positive correlation was demonstrated between the expression of genes tadC and flp and biofilm formation of VV. In addition, virulence genes (impD-H and clpV-1) related to T6SS exhibited association with survival rate in the serum. Furthermore, VV from the world displayed a divergent population structure with extensive diversification based on comparative genomics. In the present study, a large and geographically diverse strains were included, encompassing environmental, seafood and clinical strains. MLST revealed VV infections appeared sporadic. Comparative genomics analysis based on core genome clearly classified all isolates into three distinct evolutionary lineages. The vast majority of cases occurred in the United States. The possible reason is that few countries, with the exception of the United States, maintain dedicated and legally enforced surveillance systems for Vibrio species.17 With an increase in the incidence of VV infections, especially for those emerging with global warming, more attention should be paid to systematical monitoring of VV in different sources and locations.3 The pathogenesis of VV is multi-faceted, but poorly understood. A wide array of putative virulence factors were involved in VV possess, such as acid neutralization, capsular polysaccharide, iron acquisition, cytotoxicity systems, motility, and proteins related to attachment and adhesion.3,18 Unfortunately, no single virulence gene has been identified as a critical factor for human virulence. Similarly, we found no obvious difference between strains isolated from blood and puncture fluid based on genomic analysis. Therefore, the hunt for specific molecular markers that could distinguish pathogenic and non-pathogenic VV needs to be continued. Biofilms are three-dimensional complex matrix structures that might favor cross-contamination of aquatic organisms, such as Vibrio species.19 Previous studies demonstrated that biofilm formation is important for the ecology, transmission and virulence of VV and V. parahaemolyticus.20,21 The isolates variability could lead to the heterogeneous biofilm formation.22,23 The tendency of biofilm formation increased with the time in all six VV isolates, especially for isolates 25506 and 30896 with genes tadC and flp. As previous study noted, the tad operons encode the machinery required for adhesive Flp pili biogenesis for VV, resulting in increased biofilm formation, auto-aggregation, and oyster colonization.24 In addition, Pu et al found deletion of flp altered the near-surface motility profile of VV that diminished bacteria-surface interactions.25 However, this area of research remains underdeveloped. Therefore, understanding the roles of Flp pili for motility during biofilm development remains an important area of investigation. T6SS, as a molecular syringe composed of 13 essential proteins, plays an important role in the injection of cytotoxic effectors into neighbouring cells.26 T6SS has been implicated in both anti-prokaryotic and anti-eukaryotic activity as well.27,28 The isolate 19656 was lacking one genomic island including virulence genes (impD-H, clpV-1) related to T6SS, causing the survival rate to be less than 20% in the anti-complement killing test. These findings suggest that the T6SS may be good potential to serve as a predictive index of pathogenic VV in clinical infections. Further studies to evaluate this possibility are warranted. This study has several limitations. First, the included sample size for phenotypic identification was small. However, a system evaluation for evolutionary relationship was performed in the present study. In addition, the pathogenicity of VV isolates was not further confirmed by animal experiments. Therefore, a further large-scale study is needed for better evaluation of specific epidemiological factors and potential significance of virulence genes for driving VV infections.

Conclusions

In conclusion, VV infections occurred as sporadic cases. Virulence genes (impD-H, clpV-1) related to T6SS were associated with pathogenicity phenotype of VV. In addition, future investigations involving more human and non-human isolates will be required to identify reliable correlation between virulence genes and observed virulence.
  27 in total

Review 1.  Chemicals and biological products used in south-east Asian shrimp farming, and their potential impact on the environment--a review.

Authors:  S Gräslund; B E Bengtsson
Journal:  Sci Total Environ       Date:  2001-12-03       Impact factor: 7.963

2.  Potentially human-virulent Vibrio vulnificus isolates from diseased great pompano (Trachinotus goodei).

Authors:  Alicia Gibello; Ana Isabel Vela; Eva Martínez-Nevado; Antonio Rodriguez-Bertos; Almudena Casamayor; Javier García; Lucas Domínguez; Pablo Montoto; Jose Francisco Fernández-Garayzábal; Carmen Amaro
Journal:  Transbound Emerg Dis       Date:  2019-04-15       Impact factor: 5.005

Review 3.  A view to a kill: the bacterial type VI secretion system.

Authors:  Brian T Ho; Tao G Dong; John J Mekalanos
Journal:  Cell Host Microbe       Date:  2013-12-11       Impact factor: 21.023

4.  Characterization of extracellular virulence properties and biofilm-formation capacity of Vibrio species recovered from ready-to-eat (RTE) shrimps.

Authors:  Abeni Beshiru; Etinosa O Igbinosa
Journal:  Microb Pathog       Date:  2018-04-11       Impact factor: 3.738

Review 5.  Molecular Pathogenesis of Vibrio vulnificus.

Authors:  Paul A Gulig; Keri L Bourdage; Angela M Starks
Journal:  J Microbiol       Date:  2005-02       Impact factor: 3.422

Review 6.  Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment.

Authors:  Y C Chuang; C Y Yuan; C Y Liu; C K Lan; A H Huang
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

7.  Interactive Tree Of Life (iTOL) v4: recent updates and new developments.

Authors:  Ivica Letunic; Peer Bork
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

8.  Analysis of Genetic Diversity and Antibiotic Options for Clinical Listeria monocytogenes Infections in China.

Authors:  Wei Yu; Yicheng Huang; Chaoqun Ying; Yanzi Zhou; Li Zhang; Jiajie Zhang; Yingsha Chen; Yunqing Qiu
Journal:  Open Forum Infect Dis       Date:  2021-04-09       Impact factor: 3.835

9.  Type VI secretion system MIX-effectors carry both antibacterial and anti-eukaryotic activities.

Authors:  Ann Ray; Nika Schwartz; Marcela de Souza Santos; Junmei Zhang; Kim Orth; Dor Salomon
Journal:  EMBO Rep       Date:  2017-09-14       Impact factor: 8.807

10.  The type VI secretion system deploys antifungal effectors against microbial competitors.

Authors:  Katharina Trunk; Julien Peltier; Yi-Chia Liu; Brian D Dill; Louise Walker; Neil A R Gow; Michael J R Stark; Janet Quinn; Henrik Strahl; Matthias Trost; Sarah J Coulthurst
Journal:  Nat Microbiol       Date:  2018-07-23       Impact factor: 17.745

View more
  1 in total

Review 1.  Membrane Efflux Pumps of Pathogenic Vibrio Species: Role in Antimicrobial Resistance and Virulence.

Authors:  Jerusha Stephen; Manjusha Lekshmi; Parvathi Ammini; Sanath H Kumar; Manuel F Varela
Journal:  Microorganisms       Date:  2022-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.